Assignee
BIAL PORTELA & Cª S A
PT·4 granted patents·6 pending applications·9 citations·filing 2013–2021
Top patents by PatentIndex Score
10 records- 0184US9630955B2Chemical compound useful as intermediate for preparing a catechol-O-methyltransferase inhibitorBIAL—PORTELA & Cª S A·Filed 2015·Granted Apr 25, 2017·7 cites·12 claims
- 0275US10583130B2Pharmaceutical formulations compromising nitrocatechol derivatives and methods of making thereofBIAL—PORTELA & Cᵃ S A·Filed 2018·Granted Mar 10, 2020·2 cites·24 claims
- 0359US10975083B2Blood-brain barrier-penetrant dopamine-β-hydroxylase inhibitorsBIAL—PORTELA & Cᵃ S A·Filed 2017·Granted Apr 13, 2021·0 cites·21 claims
- 0454US11434242B2Dopamine-b-hydroxylase inhibitorsBIAL PORTELA & Cª S A·Filed 2018·Granted Sep 6, 2022·0 cites·14 claims
- 0554US2023398105A1Treatment regimens for parkinson's diseaseBIAL PORTELA & Cª S A·Filed 2021·Application pending·0 cites
- 0652US2016051560A1Treatments involving eslicarbazepine or eslicarbazepine acetateBIAL PORTELA & Cª S A·Filed 2014·Application pending·0 cites
- 0748US2017001962A1Processes for the Synthesis of Substituted Urea CompoundsBIAL-PORTELA & Cª S A·Filed 2015·Application pending·0 cites
- 0847US2019008774A1Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the sameBIAL PORTELA & Cª S A·Filed 2018·Application pending·0 cites
- 0941US2015197503A1Process for the synthesis of substituted urea compoundsBIAL PORTELA & Cª S A·Filed 2013·Application pending·0 cites
- 1037US2016166560A1Urea Compounds and Their Use as FAAH Enzyme InhibitorsBIAL PORTELA & Cª S A·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BIAL PORTELA & Cª S A files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →